Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference Call May 20, 2024 12:30 PM ET Company Participants Jacqueline Shea - President & Chief Executive Officer Michael Sumner - Chief Medical Officer Unidentified Analyst Welcome to the H.C. Wainwright 2nd Annual BioConnect Investor Conference at Nasdaq. For this session, we are glad to have Ms. Jacqueline Shea, President and CEO of Inovio, and Mr. Michael Sumner, Chief Medical Officer of Inovio [indiscernible]. We ...